The Smartcella group of companies is focused on developing early-stage biotechnology and medical devices to bring them to the market. The group consists of Procella Therapeutics AB, Smartwise AB, SmartCella Solutions AB and the mother company SmartCella Holding AB.

Procella Therapeutics AB is the largest company and focuses on developing cardiac stem cell technology leveraging research from Harvard University and Karolinska Institutet, with the aim of treating heart failure. Procella is collaborating with AstraZeneca to take its first cellular product candidate from pre-clinical stage to first-in-human studies and, if successful in early trials, further development towards commercial manufacture.